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The effects of low dose ultraviolet (UV) radiation on
delayed type hypersensitivity responses to tuberculin
purified protein derivative were investigated in 17
healthy, Mantoux-positive volunteers. Suberythemal and
erythemal doses of solar simulated UV from a fluorescent
lamp source were delivered to the subjects’ lower backs
daily for five consecutive days. Mantoux testing with
intradermally injected purified protein derivative was
then performed at both the irradiated sites and an
adjacent, unirradiated site, and the Mantoux induced
erythema was quantitated 72 h later with a reflectance
erythema meter. In comparison with the unirradiated
Mantoux sites, Mantoux induced erythema was signific-
antly reduced at the irradiated test sites. In six subjects,
Ultraviolet (UV) radiation induced immunosuppressionis widely believed to play an important, promotionalrole in cutaneous carcinogenesis (Streilein et al, 1994).In humans, there have so far been relatively few studiesof the effects of UV on delayed type hypersensitivity
(DTH) responses to intradermally injected recall antigens (Hersey et al,
1987; Cestari et al, 1995; Moyal et al, 1997). Mantoux testing with
purified protein derivative (PPD) is performed on the forearms of most
previously untested hospital staff, so there is a large and readily accessible
pool of potential volunteers. The Mantoux reaction could thus provide
a convenient model for assessing the immunoprotective properties of
various sunscreens. In addition, UV suppression of the Mantoux
reaction would be clinically important per se. It is well known that
individual subjects may display different sized Mantoux reactions at
different times (Chaparas et al, 1985) and it may be that this variability
is, at least partly, due to UV induced immunosuppression at sun
exposed sites. This would have obvious implications for the current
approach to Mantoux testing worldwide, because false negative
Mantoux reactions might result from sun exposure prior to testing.
MATERIALS AND METHODS
Subjects Seventeen healthy volunteers (11 women and six men) of
Fitzpatrick’s skin types I–V (Fitzpatrick, 1988) were recruited from the local
hospital staff. All had previously been vaccinated with bacille Calmette-Guerin
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we compared the effects of chronic versus short
term UV irradiation on the Mantoux reaction. These
volunteers were irradiated on one side of their lower
backs with the 5 d UV protocol, and on the other side
of their backs for 4 or 5 wk. In all but one
subject, the short irradiation protocol induced greater
suppression of Mantoux responses than prolonged UV
exposure. We conclude that even suberythemal doses
of UV significantly reduce delayed type hypersensitivity
responses to purified protein derivative, and that
an adaptive mechanism appears to counteract the
immunosuppressive effects of chronic irradiation. Key
words: delayed hypersensitivity/immunosuppression/tuberculin.
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and were known to be Mantoux positive, and none had experienced sun
exposure of their backs for at least 4 wk preceding the study. The dose of PPD
was chosen by either reviewing the subjects’ previous intensity of Mantoux
reaction, or performing an initial Mantoux test the week before irradiation
with three different doses of PPD diluted to a volume of 0.05 ml in 0.9%
normal saline. Ethical approval was obtained for these experiments from both
the Sydney University and the Royal Prince Alfred Hospital Ethics Committees,
and all volunteers provided written informed consent prior to entry into
the study.
UV irradiation The UV source was an alternating array of two UVB (20 W
Philips TL12) and six UVA (20 W NEC T10) fluorescent lamps. The lamps
were filtered with 0.5 mm cellulose triacetate film (Eastman Kodak, Rochester,
NY) to prevent transmission of UVC (,290 nm) and to attenuate the shorter
wavelength UVB emission in order to generate a spectrum more closely
approximating sunlight. Spectral irradiance of the filtered lamp array was
measured at the Commonwealth Scientific and Industrial Research Organization
(Sydney, Australia) (Damian et al, 1997a). The integrated irradiance of the lamps
at the skin surface was 0.3245 mW per cm2 UVB and 4 mW per cm2 UVA,
determined daily with an IL1350 broadband radiometer using SED 038 (UVA)
and SED 240 (UVB) detectors calibrated against the source (Commonwealth
Scientific and Industrial Research Organization).
The relative spectral irradiance curve of the UV source was similar to the
solar spectrum within the wavelength range 290–360 nm, although the
fluorescent lamps emitted relatively less longer wavelength UVA than sunlight.
The minimal erythema dose (MED) using this UV source was first determined
for each subject as the lowest dose of UVB at which clearly demarcated
erythema was seen. The volunteers then had separate areas on their lower backs
irradiated daily with different UV doses, comprising two fixed doses (95 and
150 mJ per cm2 UVB, with 1.23 and 1.94 J per cm2 accompanying UVA,
respectively) and a third dose equal to each subject’s MED (mean MED of the
17 volunteers was 152 mJ per cm2 UVB; range 100–360). Subjects were
irradiated through a 6 3 2 cm template, and different 2 3 2 cm areas within
the template were randomly selected in each subject for daily irradiation with
the three different UV doses. By varying the irradiation sites within the template,
the potential influence of anatomical location on immunoreactivity was removed
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Figure 1. A dose response is seen for EI and the diameter of Mantoux
reactions varying with the log of PPD dose. Twelve subjects, three doses
of PPD per subject.
(van Strien and Korstanje, 1994). An adjacent, unirradiated area of skin served
as a control. Six subjects were also given a daily UV protocol equivalent to 0.8
of their MED for both 5 d and, on the opposite sides of their backs, either 4
or 5 wk.
Mantoux testing After the final irradiation, PPD was intradermally injected
with 29 gauge needles at each of the test sites and also at the unirradiated
control site. The resultant Mantoux reactions were assessed 72 h later using a
reflectance erythema meter (Diastron, Hampshire, U.K.) to quantitate Mantoux
induced erythema. The erythema index (EI) was calculated as the difference
between the erythema reading at the Mantoux test site and the erythema
reading of adjacent skin. All readings with the reflectance meter were taken in
triplicate with subjects resting in the prone position, and an average reading
was then calculated for each site.
The diameter of induration at each test site was also measured using the ‘‘pen
method’’ traditionally used in clinical practice (Bouros et al, 1991), whereby a
ballpoint pen is used to determine the diameter of induration by drawing a line
towards the Mantoux reaction. When the tip of the pen reaches the outer limit
of induration, the pen comes to a halt. A line is drawn in this manner on both
sides of the reaction, and the distance between them is measured with a ruler.
Analysis of data UV immunosuppression was determined by comparing the
Mantoux induced EI at various test sites with the EI at an unirradiated control
site. Percentage immunosuppression at each site was calculated as
EI(control) – EI(test site)
%immunosuppression 5 3 100%
EI(control)
The same method was used to calculate percentage changes in the Mantoux
diameters. Statistical comparisons were made by comparing erythema/induration
at the control site with erythema/induration at irradiated test sites via paired
two tailed Student’s t tests. Results were considered significant if p , 0.05,
and are presented as mean 6 SEM. Correlations, using linear regression analysis,
were also considered significant if p , 0.05.
RESULTS
Subjects None of the subjects suffered significant adverse effects
from the Mantoux testing, and all eligible volunteers completed the
study. The average age of the 17 subjects was 37 y (range 21–53) and
the fixed dose of UV used for irradiation (95 mJ per cm2 UVB with
the accompanying UVA) was 0.7 of the mean MED (range 0.26–0.95).
The six subjects in whom acute and chronic UV protocols were
compared had a mean age of 35 y and an MED of 162 mJ per cm2
(range 110–230), so that the average UV dose given in this experiment
was 129 mJ per cm2 (0.8 MED).
A dose response is seen with increasing doses of PPD In 12
subjects who received an initial Mantoux test with three different doses
of PPD, the erythema and induration of the Mantoux reactions was
seen to rise in a linear manner when plotted against the log of the
PPD dose (Eun and Marks, 1990) (Fig 1). Although numbers of
subjects were small, the plots of EI and Mantoux diameter were almost
parallel (r 5 0.95; p , 0.05).
The Mantoux reaction is suppressed by low dose UV
radiation A dose–response relationship was seen between increasing
Figure 2. Significant suppression of PPD induced erythema was seen
with suberythemal doses of UV. The mean MED of the 17 subjects was
152 mJ UVB per cm2; 95 mJ thus corresponds to µ0.7 of the mean MED,
and 150 mJ corresponds to µ1 MED (mean 1 SEM; *p , 0.001; compared
with unirradiated site; paired two tailed Student’s t test).
Figure 3. Ultraviolet induced immunosuppression of DTH to tuberculin
PPD (Mantoux test). This subject displayed a 52% reduction in PPD induced
erythema with a suberythemal dose of 95 mJ per cm2 per day for five consecutive
days. In contrast, the diameter of induration at the irradiated sites was reduced
by only 25% when compared with the Mantoux reaction of unirradiated skin
(‘‘no UV’’).
doses of UV radiation and suppression of Mantoux induced erythema
(Figs 2, 3). Using the erythema meter to compare the reactions of
irradiated and unirradiated skin, there was significant immunosuppres-
sion after even suberythemal doses of UV. Using the erythema meter
to compare the Mantoux reactions of irradiated skin with unirradiated
control sites, the lowest UV dose (95 mJ per cm2) resulted in mean
immunosuppression of 21.4% (range –22.2–54.8; n 5 17; p , 0.001).
Doses of UV equal to the MED of 13 subjects resulted in 40.6% mean
reduction in Mantoux induced erythema (range 2.8–100; p , 0.001)
and doses of 150 mJ per cm2 caused 47.6% mean immunosuppression
(range 22.5–87.8; n 5 13; p , 0.001). There was a nonsignificant
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Figure 4. Acute, suberythemal UV radiation (5 d) resulted in greater
immunosuppression of Mantoux induced erythema (EI) than chronic
irradiation using the same daily dose for 4–5 wk. There was a trend
towards greater suppression of Mantoux induced induration (φ) with the shorter
protocol (mean 1 SEM; n 5 6; **p , 0.01, *p , 0.05; irradiated sites
compared with unirradiated control; paired two tailed Student’s t test).
trend towards reduction in diameters of the Mantoux reactions with
increasing doses of UV. The lowest dose (95 mJ per cm2) resulted in
a 5.5 6 4.4% reduction in induration and this increased to 7.4 6 5.3%
with 1 MED. With the larger, generally erythemal dose of 150 mJ
per cm2 per day, there was a slight increase in Mantoux diameter
(2.6 6 5.6%).
There was no relationship between age or MED and susceptibility
to immunosuppression by low dose UV (r 5 0.01 and 0.003,
respectively); subjects with darker skin, either through constitutive
or facultative pigmentation, were just as immunosuppressed as the
paler subjects.
Elicitation of Mantoux responses in unirradiated skin is not
impaired by low dose irradiation of adjacent skin In the 12
volunteers who underwent a separate Mantoux test with the same
dose of PPD used for assessing UV immunosuppression, but without
prior exposure of their lower backs to the UV protocol, the
intensity of DTH at unirradiated sites did not appear to be reduced
by exposure of adjacent skin to the UV protocol, but was
nonsignificantly higher (unpaired two tailed Student’s t test). The
mean EI of the 12 Mantoux reactions without prior UV was
84.4 6 9.2, compared with 116.9 6 13.4 with UV.
Acute, low dose UV is more immunosuppressive than chronic
UV irradiation Of the six subjects who completed both the short
(5 d) protocol and also the 4 or 5 wk irradiation, all but one
demonstrated greater immunosuppression with the shorter protocol.
On average, the 5 d protocol resulted in mean immunosuppression
of 41.6% using the erythema meter (range 25.2–54.8; p , 0.01
when compared with unirradiated Mantoux sites) and 12.2% by
diameter (range –17.9–29.4; not significant) (Fig 4). Chronic
irradiation caused only 17% mean immunosuppression by EI (range
0–34.2; p , 0.05) and –0.7% by diameter (range –54.5–29; not
significant). Percentage immunosuppression caused by the acute UV
protocol was therefore µ2.5 times that induced by prolonged
irradiation (as measured with the erythema meter).
DISCUSSION
Using an irradiation protocol simulating low dose, daily sun exposure,
we found significant reduction in DTH responses to tuberculin
PPD, with all but one subject being immunosuppressed to some
degree. Previously, we used an identical, suberythemal irradiation
protocol (95 mJ per cm2 per day, using the same UV source) to
examine UV immunosuppression of contact hypersensitivity to nickel
in nickel-allergic volunteers (Damian et al, 1997b). UV induced
suppression of nickel contact hypersensitivity was found to be a
specific immunologic effect, because irradiation had no effect on
nonspecific inflammation caused by an irritant, sodium lauryl sulfate.
Mean nickel induced erythema was reduced by 35% in a group of
16 volunteers of similar age and skin type to the Mantoux subjects
who were, in contrast, immunosuppressed by only 21%. It appears
that contact hypersensitivity to recall antigens is more easily
suppressed by solar simulated UV than DTH.
In our Mantoux model, the diameters of induration were not
significantly reduced by UV irradiation, despite there being a
significant reduction in Mantoux induced erythema. In clinical
practice, measurement of Mantoux diameter (as opposed to
measurement of erythema) is used to determine whether a test is
regarded as negative or positive. Generally, a diameter of less than
5 mm is considered a negative reaction. Whereas measurement of
diameter is still clinically useful and convenient, it cannot differentiate
more subtle changes in the intensity of DTH. It seems likely that,
at the small PPD doses used in our study, the diameter of induration
may reflect the initial volume of fluid injected rather than the true
intensity of the immune reaction. Injection of 5 units of PPD
causes immediate distension of the dermis, which probably determines
the ultimate width, if not the depth, of induration. An analogy can
be drawn with patch testing, as used in our nickel model. In most
patch test reactions, the diameter of induration corresponds to the
1 cm diameter test site, whereas the thickness and erythema of
these reactions can vary markedly. It is only in very weak reactions
that diameters of induration are less than 1 cm and, conversely,
only the most intense reactions cause spreading of the reaction
beyond the original 1 cm patch. Previous studies of UV effects on
tuberculin DTH in humans have relied solely on the diameter of
induration, rather than on erythema. Moyal et al (1997) were able
to induce significant reductions in the diameters of reactions, but
only with very large, erythemal doses of UV delivered to more
extensive areas of skin. Earlier work by Hersey et al failed to
demonstrate reduced PPD induced induration, but used much
smaller doses of UV, more closely reflecting typical daily sun
exposure (Hersey et al, 1987).
In order to determine whether our UV protocol induced systemic
as well as local suppression of Mantoux responses, 12 of the 17
volunteers were also Mantoux tested on the contralateral back
without any recent exposure to the UV protocol. These reactions were
actually nonsignificantly smaller than those elicited at unirradiated sites
immediately after the UV protocol, whereas the opposite would be
expected if systemic immunosuppression had occurred. A likely
explanation for the marginal increase in DTH intensity between
the initial Mantoux test (no UV) and the subsequent Mantoux test
(with UV) is boosting of DTH through repeated testing within a
short time frame (1–2 wk) (Thompson et al, 1979). Whilst recent
work by Moyal et al (1997) found that exposure of volunteers to
large doses of UV delivered to large surface areas produced significant
systemic as well as local suppression of DTH responses, our results
suggest that systemic immunosuppression does not occur if very
small doses of UV are delivered to small areas of skin. Total UV
per cm2 in our 5 d protocol was µ3.5 MED, delivered to a total
surface area of only 6 cm2, compared with 14.5 MED per cm2
delivered to 1200 cm2 in Moyal et al’s protocol.
Our findings suggest that chronic UV irradiation may induce
adaptive mechanisms that help counteract the immunosuppression
associated with acute UV exposure. It has previously been shown
that in mice (Alcalay and Kripke, 1991), and possibly humans
(Bergfelt, 1993), acute UV exposure is associated with an initial
decrease in Langerhans cells, followed by an increase towards normal
numbers as irradiation continues. Because there was no correlation
between skin color and susceptibility to UV immunosuppression of
Mantoux reactions, it seems unlikely that facultative pigmentation
(tanning) plays a role in this adaptive process.
We conclude that even modest doses of UV can significantly
reduce local DTH responses to recall antigens, and that recent sun
exposure should be considered a possible cause of false negative
Mantoux responses.
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